Neurocrine Biosciences, Inc. (NBIX) Posts Q1 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $151.83 --0%
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Versant Media Group (VSNT) PT Lowered to $43 at Goldman Sachs
- Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
